When the tumor releases a large number of highly expressed costimulatory molecules of EVs, APCs or DCs can directly present the antigen to CD8+ T cells[97], stimulate their synthesis of IL-2 and proliferation and differentiation into CTL with a specific killing effect on tumor cells. This evidence concerns the gene CD8A and neoplasm.